You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritis

Article metrics

Article menu
Epidemiology and outcomes
Original research
Immunogenicity of the third and fourth BNT162b2 mRNA COVID-19 boosters and factors associated with immune response in patients with SLE and rheumatoid arthritis

 

Online download statistics by month:

Online download statistics by month: July 2022 to September 2024

AbstractFullPdf
Jul 202216917338
Aug 2022492515141
Sep 202222523165
Oct 202217117146
Nov 2022929126
Dec 2022676636
Jan 2023787527
Feb 2023727430
Mar 2023837633
Apr 2023585434
May 2023585132
Jun 2023514921
Jul 2023433916
Aug 2023373613
Sep 202343364
Oct 2023383517
Nov 2023464411
Dec 2023303012
Jan 2024353321
Feb 2024363011
Mar 2024414092
Apr 2024555422
May 2024484712
Jun 2024574819
Jul 2024494116
Aug 2024262412
Sep 2024252416
Total22252187823